首页> 外国专利> Method of differentiation of thyroid neoplastic lesions, kit for implementation of this method and the use of metallothionein (MT) for the differentiation of thyroid neoplastic lesions

Method of differentiation of thyroid neoplastic lesions, kit for implementation of this method and the use of metallothionein (MT) for the differentiation of thyroid neoplastic lesions

机译:分化为甲状腺肿瘤病变的方法,实施该方法的试剂盒以及金属硫蛋白(MT)在分化为甲状腺肿瘤病变中的用途

摘要

A method of differentiating oncogenic changes of the thyroid encompassing follicular adenoma and follicular cancer, characterised in that in a sample of oncogenic tissue from a patient the expression of the metallothionein (MT) potein is evaluated using immunochistochemical methods using monoclonal anti-MT antibodies, the degree of intensity of the expression of metallothionein is evaluated under a light microscope using the semiquantitative IRS method according to Remmele, wherein if the degree of intensity of the expression of metallothionein is equal to or greater than 8 on the semiquantitative IRS scale then the presence of follicular cancer is indicated.
机译:一种区分包括滤泡性腺瘤和滤泡性癌在内的甲状腺的致癌性变化的方法,其特征在于,在来自患者的致癌组织样品中,使用单克隆抗MT抗体的免疫组织化学方法评估金属硫蛋白(MT)波坦的表达。根据Remmele的半定量IRS方法,在光学显微镜下评估金属硫蛋白表达强度,其中如果金属硫蛋白表达强度在半定量IRS等级上等于或大于8,则存在提示滤泡癌。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号